Clinical Trial Update: Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCV [Phase 3]

View source ↗

Summary

Phase 3 trial of grazoprevir/elbasvir for acute hepatitis C in people with HIV has completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Grazoprevir/Elbasvir

Snippet

Sponsor: Erasmus Medical Center | Conditions: Acute Hepatitis C, Human Immunodeficiency Virus | Phase 3 | Status: COMPLETED | Results posted: 2019-07-08